Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape.
di Tomaso E, Snuderl M, Kamoun WS, Duda DG, Auluck PK, Fazlollahi L, Andronesi OC, Frosch MP, Wen PY, Plotkin SR, Hedley-Whyte ET, Sorensen AG, Batchelor TT, Jain RK. Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape. Cancer Res. 2011 Jan 01; 71(1):19-28.
-
Dan Gabriel Duda, Ph.D., D.M.D.
-
Tessa Hedley-Whyte, M.D., M.B.,B.S.
-
Rakesh K. Jain, Ph.D.
-
Scott Randall Plotkin, M.D.,Ph.D.
-
Patrick Yung Chih Wen, M.D.
-
Ovidiu C Andronesi, Ph.D., M.D.
-
Tracy Todd Batchelor, M.D.
-
Matthew P. Frosch, M.D.,Ph.D.